All-printed point-of-care immunosensing biochip for one drop blood diagnostics
Citations Over TimeTop 15% of 2022 papers
Abstract
Designing and preparing a fast and easy-to-use immunosensing biochip are of great significance for clinical diagnosis and biomedical research. In particular, sensitive, specific, and early detection of biomarkers in trace samples promotes the application of point-of-care testing (POCT). Here, we demonstrate an all-printed immunosensing biochip with the characteristics of hydrodynamic enrichment and photonic crystal-enhanced fluorescence. Direct quantitative detection of cardiac biomarkers via one drop of blood is achieved in 10 min. After simulating the hydrodynamic behavior of one droplet serum on the printed assay, creatine kinase-MB (CK-MB) has been recognized and located on the photonic crystal arrays. Benefiting from the fluorescence enhancement effect, quantitative detection of CK-MB has been demonstrated from 0.01 ng ml-1 to 100 ng ml-1, which is superior to the conventional enzyme-linked immunosorbent assay (ELISA). This strategy provides a general and easy-to-use approach for fast quantitative detection of biomarkers, which would be improved further for portable clinical diagnostics and home medical monitoring.
Related Papers
- → Field-testing and validation in a primary care setting of a point-of-care test for C-reactive protein(2003)41 cited
- Principles & practice of point-of-care testing(2002)
- Thrombosis and hemostasis testing at the point of care.(1995)
- → 3. Point of Care: Useful Clinical Examination and Ultrasonography, 1) Clinical Laboratory Test: Point of Care Testing, Cardiac Marker (Mainly Cardiac Troponin)(2019)
- → Point of Care Testing : Now and Future(<Special Issue>Micro-Machine Technology and Point of Care Testing (POCT))(2002)